IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 39 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,230,625 | +1.8% | 716,613 | 0.0% | 0.07% | +17.5% |
| Q3 2022 | $7,102,000 | +17.3% | 716,613 | +16.1% | 0.06% | +37.0% |
| Q2 2022 | $6,053,000 | 0.0% | 617,001 | 0.0% | 0.05% | -43.9% |
| Q1 2022 | $6,053,000 | +0.9% | 617,001 | 0.0% | 0.08% | +34.4% |
| Q4 2021 | $5,997,000 | +0.3% | 617,001 | 0.0% | 0.06% | -24.7% |
| Q3 2021 | $5,979,000 | -0.5% | 617,001 | -0.8% | 0.08% | +11.0% |
| Q2 2021 | $6,012,000 | – | 621,750 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |